|
Sapanisertib Clinical Trials
2 actively recruiting trials across 2 locations
Also known as: FTH-003, INK-128, INK128, MLN-0128, MLN0128, TAK-228
Irvine, California1 trial
Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Phase 1/2
La Jolla, California1 trial
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
UC San Diego Moores Cancer Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.